<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ivm</journal-id><journal-title-group><journal-title xml:lang="ru">Международный вестник ветеринарии</journal-title><trans-title-group xml:lang="en"><trans-title>International Journal of Veterinary Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-2419</issn><publisher><publisher-name>SpbGUVM Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52419/issn2072-2419.2024.2.24</article-id><article-id custom-type="elpub" pub-id-type="custom">ivm-1366</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФЕКЦИОННЫЕ БОЛЕЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFECTIOUS DISEASES</subject></subj-group></article-categories><title-group><article-title>Лечение экспериментального септического артрита цыплят, вызванного золотистым стафилококком</article-title><trans-title-group xml:lang="en"><trans-title>Treatment of experimental septic arthritis of chickens caused by staphylococcus aureus</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9380-4136</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юрин</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yurin</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> канд. ветеринар. наук, вед. науч. сотр. </p></bio><bio xml:lang="en"><p> C. V. Sc., Leading Researcher </p></bio><email xlink:type="simple">bes512@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9629-0000</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скворцов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Skvortsov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p> д-р ветеринар. наук, руководитель филиала</p></bio><bio xml:lang="en"><p> D. V. Sc., Head of Department </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7586-6667</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логвинова</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Logvinova</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p> мл. науч. сотр. </p></bio><bio xml:lang="en"><p> Junior Researcher </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белгородский филиал ФГБНУ «Федеральный научный центр – Всероссийский научно - исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко РАН»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Belgorod Department of FGBNU "Federal Scientific Centre – All-Russian Research Institute of Experimental Veterinary Medicine named after K. I.  Scriabin and Ya. R. Kovalenko of Russian Academy of Sciences"</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>28</day><month>06</month><year>2024</year></pub-date><volume>0</volume><issue>2</issue><fpage>24</fpage><lpage>30</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юрин Д.В., Скворцов В.Н., Логвинова С.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Юрин Д.В., Скворцов В.Н., Логвинова С.С.</copyright-holder><copyright-holder xml:lang="en">Yurin D.V., Skvortsov V.N., Logvinova S.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vetjournal.spbguvm.ru/jour/article/view/1366">https://vetjournal.spbguvm.ru/jour/article/view/1366</self-uri><abstract><p>Решение проблемы септического артрита птиц, вызванного Staphylococcus aureus, является серьезной задачей для современного птицеводства. Было проведено исследование эффективности применения антимикробных препаратов из разных групп при лечении цыплят двухнедельного возраста, зараженных с исследовательской целью. В первом опыте установлена эффективность флорфеникола, офлоксацина и комбинированного препарата, в состав которого входят ципрофлоксацин и апрамицин (100+500 мг/г), при выпаивании цыплятам с водой за сутки до заражения. Флорфеникол и офлоксацин назначались в дозах 300; 200; 100 и 50 мг/л, а комбинированный препарат – 200; 100; 50 и 25 мг/л воды (по ципрофлоксацину). Во втором опыте изучалась эффективность тилмикозина, назначаемого с водой в дозах 500; 250; 125 и 62,5 мг/л одновременно с заражением. Для заражения цыплят использована патогенная культура S. aureus. Суспензию возбудителя вводили внутрибрюшинно из расчёта 300 миллионов микробных тел в 0,5 мл 0,9% раствора NaCl (№2 по шкале мутности MсFarland) на цыпленка. Наблюдение за птицами вели в течение 20 дней, учитывая их заболеваемость и смертность. Установлено, что при лечении цыплят, начатом за сутки до заражения, наиболее эффективно применение флорфеникола, и, в меньшей степени, комбинированного препарата на основе ципрофлоксацина и апрамицина. В этом случае обеспечивалась сохранность от 84 до 96% зараженных цыплят. Назначение офлоксацина с водой за сутки до заражения цыплят не имело практического значения, так как независимо от дозы препарата наблюдались высокие заболеваемость и смертность животных, соответствующие или превышающие таковые в контрольной группе. Назначение тилмикозина с водой одновременно с заражением цыплят показало умеренную эффективность в средних и низких дозах (125 и 62,5 мг/л). Однако, при этом наблюдалась высокая смертность поголовья, а количество переболевших достигало 56%.</p></abstract><trans-abstract xml:lang="en"><p>Addressing the problem of septic arthritis, caused by Staphylococcus aureus, is a matter of high importance for poultry industry nowadays. We conducted research into effectiveness of antimicrobials of different groups used for treating experimental infection in two-week old chicks. In the first experiment we determined the effectiveness of florfenicol, ofloxacin and a compound drug, containing ciprofloxacin and apramycin (100 mg/g and 500 mg/g). Florfenicol and ofloxacin were administered at concentrations 300 mg/L, 200 mg/L, 100 mg/L and 50 mg/L of drinking water, while the compound drug – 200 mg/L, 100 mg/L, 50 mg/L and 25 mg/L (considering ciprofloxacin). In the second experiment we studied the effectiveness of tilmicosin, administered via drinking water at concentrations 500 mg/L, 250 mg/L, 125 mg/L and 62.5 mg/L simultaneously with the challenge. For the challenge of the chicks, we used pathogenic culture of S. aureus. S. aureus in suspension was injected intraperitoneally at a dose 3 x 108 cells in 0.5 mL of 0.9% saline (2 MсFarland standard) per chick. The observation period was 20 days during which we watched the chicks and registered their morbidity rate and mortality rate. We came to a conclusion that florfenicol was most effective when the treatment of the chicks began 24 hours prior to the challenge; in the same situation the compound drug, containing ciprofloxacin and apramycin, was slightly less effective. Under these conditions the survivability of the infected chicks was 84% to 96%. When the treatment with ofloxacin via drinking water began 24 hours prior to the challenge of the chicks, it was no use as morbidity rate and mortality rate were similar or even higher compared to the control group, irrespective of the dose. When the treatment with tilmicosin via drinking water began simultaneously with the challenge of the chicks, it was rather effective at medium and low doses of 125 mg/L and 62.5 mg/L. However, the mortality rate of the chicks was high and the morbidity rate reached 56%.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цыплята</kwd><kwd>стафилококковый артрит</kwd><kwd>экспериментальное заражение</kwd><kwd>антимикробные препараты</kwd><kwd>эффективность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chicks</kwd><kwd>staphylococcal arthritis</kwd><kwd>experimental infection</kwd><kwd>antimicrobials</kwd><kwd>effectiveness</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Данная статья была написана во время интенсивных обстрелов г. Белгорода из РСЗО со стороны украинских фашистов. Выражаем свою искреннюю благодарность расчётам ПВО, отражавшим налеты, а также всем советским и российским конструкторам, причастным к разработке зенитно-ракетных комплексов.</funding-statement><funding-statement xml:lang="en">The present article was written in a period of intensive bombardment of Belgorod with MLRS rockets by Ukranian fascists. We wish to express our sincere gratitude to the air defence forces personnel who stood up to the threat and also to all Soviet and Russian engineers, who designed and developed our anti-aicraft and anti-missile systems.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Балбуцкая А.А. Биологические свойства Staphylococcus aureus, выделенного от больной артритом птицы / А.А. Балбуцкая, В.Н. Скворцов / Ветеринарный врач. – 2019. – №1. – С. 28-33. DOI: 10.33632/1998-698X.2019-1-28-33.</mixed-citation><mixed-citation xml:lang="en">Balbutskaya A.A. Biologicheskiie svoistva Staphylococcus aureus, vydelennogo ot bol’noi artritom ptitsy [Biological properties of Staphylococcus aureus isolated from poultry with athritis] / V.N.Skvortsov, A.A. Balbutskaya // Veterinarnyi vrach [The Veterinarian], 2019, no. 1, pp. 28-33. DOI: 10.33632/1998-698X.2019-1-28-33 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">ГОСТ 34088-2017. Руководство по содержанию и уходу за лабораторными животными. Правила содержания и ухода за сельскохозяйственными животными. М., 2018. – 30 с.</mixed-citation><mixed-citation xml:lang="en">ГОСТ 34088-2017 Rukovodstvo po soderzhaniu i ukhodu za laboratotnyni zhivotnymi. Pravila soderzhania i ukhoda za sel’skokhoziastvennymi zhivotnymi [GOST 34088-2017 Guidelines for accommodation and care of laboratory animals. Rules for keeping and care of farm animals]. М., Standartinform Publ., 2018, 30 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Белимова С.С., Скворцов В.Н., Моисеева А.А., Лаишевцев А.И., Степанова Т.В., Дроздова Е.И. Изучение эффективности левофлоксацина при экспериментальном стафилококкозе цыплят // Ветеринария и кормление. – 2023. – №4. – С.4-6. DOI: 10.30917/ATT-VK-1814-9588-2023-4-1.</mixed-citation><mixed-citation xml:lang="en">Belimova S.S., Skvortsov V.N., Moiseeva A.A., Laishevtsev A.I., Stepanova T.V., Drozdova Ye.I. Izuchenie effektivnosti levofloksatsina pri eksperimental’nom stafilokokkoze tsipliat [A study of effectiveness of levofloxacin in experimental staphylococ cosis of chicks] // Veterinaria i kormlenie, 2023, no. 4, pp. 4-6. DOI: 10.30917/ATTVK-1814-9588-2023-4-1 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Andreasen CB. 2020. Staphylococcosis. In: Swayne DE, editor. Diseases of poultry. 14 th ed. Hoboken (NJ): John Wiley &amp; Sons, Ltd; – p. 995–1003.</mixed-citation><mixed-citation xml:lang="en">Andreasen CB. 2020. Staphylococcosis. In: Swayne DE, editor. Diseases of poultry. 14th ed. Hoboken (NJ): John Wiley &amp; Sons, Ltd; – p. 995–1003.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Benrabia I, Hamdi TM, Shehata AA, Neubauer H, Wareth G. 2020. Methicillinresistant Staphylococcus aureus (MRSA) in poultry species in Algeria: long-term study on prevalence and antimicrobial resistance. Vet Sci. 7(2): 54.</mixed-citation><mixed-citation xml:lang="en">Benrabia I, Hamdi TM, Shehata AA, Neubauer H, Wareth G. 2020. Methicillinresistant Staphylococcus aureus (MRSA) in poultry species in Algeria: long-term study on prevalence and antimicrobial resistance. Vet Sci. 7(2): 54.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huang JG, Hu XY, Cheng GF, Zhou SQ, Song NH (2002). The diagnosis of Staphylococcus arthritis in breeding broilers. J. Hubei Agri. Sci. 3(4): 78–79.</mixed-citation><mixed-citation xml:lang="en">Huang JG, Hu XY, Cheng GF, Zhou SQ, Song NH (2002). The diagnosis of Staphylococcus arthritis in breeding broilers. J. Hubei Agri. Sci. 3(4): 78–79.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jackson C.R., Davis J.A., Barrett J.B. Prevalence and characterization of methicillin-resistant Staphylococcus aureus isolates from retail meat and humans in Georgia. J. Clin. Microbiol. 2013; 51:1199–1207. doi: 10.1128/JCM.03166-12.</mixed-citation><mixed-citation xml:lang="en">Jackson C.R., Davis J.A., Barrett J.B. Prevalence and characterization of methicillin-resistant Staphylococcus aureus isolates from retail meat and humans in Georgia. J. Clin. Microbiol. 2013; 51:1199–1207. doi: 10.1128/JCM.03166-12.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Merck S, Corp D (2011). The Merck’s Veterinary Manual, Staphylococcosis introduction and zoonotic risk. Pp. 75–80.</mixed-citation><mixed-citation xml:lang="en">Merck S, Corp D (2011). The Merck’s Veterinary Manual, Staphylococcosis introduction and zoonotic risk. Pp. 75–80.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">National Research Council (US) Institute for Laboratory Animal Research. Guidance for the Description of Animal Research in Scientific Publications. Washington (DC): National Academies Press (US); 2011. PMID: 22379656.</mixed-citation><mixed-citation xml:lang="en">National Research Council (US) Institute for Laboratory Animal Research. Guidance for the Description of Animal Research in Scientific Publications. Washington (DC): National Academies Press (US); 2011. PMID: 22379656.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Parte AC, Sardà Carbasse J, MeierKolthoff JP, Reimer LC, Göker M. 2020. List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol. 70(11):5607–5612. (Accessed on 20 November 2021).</mixed-citation><mixed-citation xml:lang="en">Parte AC, Sardà Carbasse J, MeierKolthoff JP, Reimer LC, Göker M. 2020. List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol. 70(11):5607–5612. (Accessed on 20 November 2021).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rodgers JD, McCullagh JJ, McNamee PT, Smyth JA, Ball HJ. 1999. Comparison of Staphylococcus aureus recovered from personnel in a poultry hatchery and in broiler parent farms with those isolated from skeletal disease in broilers. Vet Microbiol. 69 (3):189–198.</mixed-citation><mixed-citation xml:lang="en">Rodgers JD, McCullagh JJ, McNamee PT, Smyth JA, Ball HJ. 1999. Comparison of Staphylococcus aureus recovered from personnel in a poultry hatchery and in broiler parent farms with those isolated from skeletal disease in broilers. Vet Microbiol. 69 (3):189–198.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Syed MA, Ullah H, Tabassum S, Fatima B, Woodley TA, Ramadan H, Jackson CR. 2020. Staphylococci in poultry intestines: a comparison between farmed and household chickens. Poult Sci. 99(9): 4549–4557.</mixed-citation><mixed-citation xml:lang="en">Syed MA, Ullah H, Tabassum S, Fatima B, Woodley TA, Ramadan H, Jackson CR. 2020. Staphylococci in poultry intestines: a comparison between farmed and household chickens. Poult Sci. 99(9): 4549–4557.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wijesurendra DS, Chamings AN, Bushell RN, Rourke DO, Stevenson M, Marenda MS, Noormohammadi AH, Stent A. 2017. Pathological and microbiological investigations into cases of bacterial chondronecrosis and osteomyelitis in broiler poultry. Avian Pathol. 46(6):683–694.</mixed-citation><mixed-citation xml:lang="en">Wijesurendra DS, Chamings AN, Bushell RN, Rourke DO, Stevenson M, Marenda MS, Noormohammadi AH, Stent A. 2017. Pathological and microbiological investigations into cases of bacterial chondronecrosis and osteomyelitis in broiler poultry. Avian Pathol. 46(6):683–694.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">World Organization for Animal Health. 2018. Chapter 1.1.4. Biosafety and biosecurity: Standard for managing biological risk in the veterinary laboratory and animal facilities, http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/1.01.04_BIOSAFETY_BIOSECURITY.pdf [accessed on February 27, 2019].</mixed-citation><mixed-citation xml:lang="en">World Organization for Animal Health. 2018. Chapter 1.1.4. Biosafety and biosecurity: Standard for managing biological risk in the veterinary laboratory and animal facilities, http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/1.01.04_BIOSAFETY_BIOSECURITY.pdf [accessed on February 27, 2019].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
